Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
*Pulmonary Disease, Chronic Obstructive
Suissa, S. ., Dell’Aniello, S. ., & Ernst, P. . (2022). Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety. Copd, 19, 109–117. http://doi.org/10.1080/15412555.2022.2035705
Whittaker, H. ., Rubino, A. ., Mullerova, H. ., Morris, T. ., Varghese, P. ., Xu, Y. ., … Quint, J. K. (2022). Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study. Int J Chron Obstruct Pulmon Dis, 17, 427–437. http://doi.org/10.2147/copd.s346591